U.S. market Closed. Opens in 52 minutes

MYNZ | Mainz Biomed B.V. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
Revenue895.48K529.88K577.35K493.56K281.39K
Cost of Revenue385.82K347.73K399.73K370.48K342.66K
Gross Profit509.66K182.15K177.62K123.08K-61.27K
Operating Expenses27.15M26.36M9.56M479.39K690.21K
Selling, General & Admin17.22M22.81M9.41M458.37K570.25K
Research & Development9.59M3.66M466.69K311.85K250.32K
Other Operating Expenses342.40K-114.05K-320.89K-290.84K-130.35K
Operating Income-26.64M-26.17M-9.38M-325.81K-921.91K
Other Expenses / Income348.95K56.70K-1.97M-261.08K-35.15K
Before Tax Income-26.30M-26.39M-11.70M-586.89K-957.05K
Income Tax ExpensesN/A65.39K377.12K299.28K217.71K
Net Income-26.30M-26.45M-12.07M-886.18K-1.17M
Interest Expenses809.58K289.32K339.17K268.79K201.94K
Basic Shares Outstanding16.24M14.16M7.21M5.61M11.71M
Diluted Shares Outstanding16.24M14.16M7.21M5.61M11.71M
EBITDA-25.01M-25.72M-11.28M-257.64K-702.08K
EBITDA Margin-2,793.05%-4,853.62%-1,953.93%-52.20%-249.50%
EBIT-25.49M-26.10M-11.36M-318.10K-755.12K
EBIT Margin-2,846.09%-4,925.30%-1,966.92%-64.45%-268.35%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙